Effects of carbenoxolone sodium on stress-induced gastric damage in rats W. E. PERKINS' AND L. VARS Central Research Laboratories, Pfizer Inc., Groton, Connecticut 06340 Carbenoxolone sodium was studied to determine its effect against restraint-induced gastric mucosal damage in the rat. Significant anti-ulcer activity was observed following intraperitoneal administration in nonfasted but not in either 24 or 48 h fasted rats. Orally, carbenoxolone had no statistically significant effect in non-fasted rats although the data suggest that it may have afforded some protection. These results indicate that the use of non-fasted rats is most probably a requirement for demonstrating the protective activity of this type of anti-ulcer compound in stressed rat assays.
Several actions may account for the antiulcer activity of carbenoxolone. It has been shown to reduce gastric acid output in response to histamine in man (Bank, Marks, Palmer, Groll & Van Eldik, 1967; Cocking & MacCaig, 1969) and to reduce the total acidity of gastric juice collected from anaesthetized pylorus ligated rats (Henman, 1970) . In addition to an effect on gastric acidity, Henman (1970) has demonstrated dose-related antipeptic activity with this compound both in vivo and in vitro and suggests that its therapeutic activity may be related in part to its effect on gastric acidity and peptic activity. A mucigogue effect may be important since histological data indicate that carbenoxolone enhances gastric mucus secretion (Goodier, Horwich & Galloway, 1967; Dean, 1967; Lipkin & Ludwig, 1967; Johnson, 1967) . Thus, carbenoxolone may be unique in that it may facilitate ulcer healing by simultaneously decreasing the digestive capacity of gastric juice and increasing mucosal resistance.
Little has been published regarding the effect of carbenoxolone in standard animal ulcer tests. Pretreatment with carbenoxolone reduces the ulcerogenic effect of compound 48/80 in rats (Dean, 1967) gastric erosions (Lipkin & Ludwig, 1967 (Sines, 1959 ) from which only the head protruded. After 20-24 h, the animals were killed by cervical dislocation and the cocoons removed. The abdomen of each rat was opened, the pylorus clamped, the stomach distended with saline (0 9% w/v NaCl solution) via an oral tube, the oesophagus clamped, and the stomach excised. The stomachs were placed in a 0 4% formaldehyde solution for approximately 30 s to harden the outer layers and facilitate examination (Brodie & Hanson, 1960) . Each stomach was then cut open along the greater curvature and the number of gastric erosions in the glandular portion (corpus and antrum) recorded. The Mann-Whitney-Wilcoxon rank sum test was used to compare the median number of gastric erosions in the control and treated groups to determine statistical significance. Carbenoxolone sodium (synthesized by Dr. R. Nelson, Medicinal Chemistry Department) was dissolved in distilled water.
Results-The results of these experiments are summarized in Tables la and b . Intraperitoneally administered carbenoxolone (40 mg/kg) had no effect on stressinduced damage in either 24 or 48 h fasted rats (Table la) . In non-fasted animals, in contrast, carbenoxolone caused a signi- (Table lb) . No anti-ulcer activity was observed in non-fasted animals at the 10 mg/kg i.p. dose (Table lb) . In nonfasted animals, carbenoxolone (160 mg/kg) given orally had no statistically significant effect against restraint-induced damage although in one experiment a 62 5 and in the other a 58 9% reduction in the total number of lesions was observed (Table Ib) .
Discussion.-It has been possible to demonstrate a protective effect of carbenoxolone sodium against stress-induced gastric glandular mucosal damage in rats. Significant anti-ulcer activity was observed with this drug in non-fasted but not in either 24 or 48 h fasted rats. The use of non-fasted rats is most probably a requirement for demonstrating the antiulcer activity of this type of compound in stressed rat assays.
No reason can be given for the difference in activity in fasted and nonfasted rats. Fasting itself is a stress and will increase the effect of other stressors (Selye, 1950) . Brodie & Hanson (1960) found that starvation (i.e., total food deprivation) increases the severity and incidence of restraint-induced gastric damage in the rat. No such effect was observed in our study, possibly because fasted rather than starved rats were used. However, it still may be that carbenoxolone is not sufficiently potent to overcome the ulcerogenic effect of synergistic stresses. Likewise, fasting may block the suggested mucigogue activity (Goodier, et al., 1967; Dean, 1967; Lipkin & Ludwig, 1967; Johnson, 1967) of this compound and, therefore, its anti-ulcer activity. This seems unlikely, however, as the data presented by Robert, Boyer & Nezamis (1963) indicate that fasting for up to 48 h does not depress the synthesis or release of gastric mucus in the rat. The possibility exists that the anti-ulcer and mucigogue activities of this compound are not directly related.
Previous studies (Dean, 1967; Lipkin & Ludwig, 1967) have demonstrated antiulcer activity following pretreatment with carbenoxolone. In our study, significant anti-ulcer activity was observed following intraperitoneal but not oral administration when the compound was administered immediately before stressing. However, the data suggest that orally administered car- benoxolone may have afforded some protection. In each of two experiments, the total number of gastric lesions was reduced by more than fifty per cent. Inability to demonstrate a significant oral anti-ulcer effect may be related to the way carbenoxolone is metabolized in the rat. Parke (1967) found that one-half to two-thirds of an oral dose of carbenoxolone is hydrolyzed to glycyrrhetinic acid and succinate in the rat gastrointestinal tract before primary absorption. Assuming carbenoxolone is the active substance, significant oral activity against restraint-induced ulcerogenesis should result on increasing the dose of drug.
